Page last updated: 2024-08-26

cb 10375 and Nervous System Disorders

cb 10375 has been researched along with Nervous System Disorders in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Brooks, N; Coley, HM; Goddard, PM; Halbert, GW; Jarman, M; Jones, M; Judson, IR; Kubota, T; Lee, N; Owens, MD	1

Other Studies

1 other study(ies) available for cb 10375 and Nervous System Disorders

Article	Year
Pre-clinical development of the anti-tumour agent CB 7646, bis N-(hydroxymethyl) trimethylmelamine, a stable analogue of trimelamol. International journal of cancer, 1996, Nov-04, Volume: 68, Issue:3 Topics: Animals; Antineoplastic Agents; Chemistry, Pharmaceutical; Cisplatin; Drug Evaluation, Preclinical; Drug Screening Assays, Antitumor; Drug Stability; Female; Humans; Male; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Nervous System Diseases; Ovarian Neoplasms; Plasmacytoma; Rats; Rats, Wistar; Solutions; Transplantation, Heterologous; Triazines; Tumor Cells, Cultured; Water	1996

Article

Year

Pre-clinical development of the anti-tumour agent CB 7646, bis N-(hydroxymethyl) trimethylmelamine, a stable analogue of trimelamol.

International journal of cancer, 1996, Nov-04, Volume: 68, Issue:3

Topics: Animals; Antineoplastic Agents; Chemistry, Pharmaceutical; Cisplatin; Drug Evaluation, Preclinical; Drug Screening Assays, Antitumor; Drug Stability; Female; Humans; Male; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Nervous System Diseases; Ovarian Neoplasms; Plasmacytoma; Rats; Rats, Wistar; Solutions; Transplantation, Heterologous; Triazines; Tumor Cells, Cultured; Water

1996